Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 20, 2018
Pharmacy Choice - News - Front Page Healthcare News - October 20, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/19/18 - 3D Surgical Microscope Systems Market Industry Analysis, Growth, Trends and Forecast 20172027: Future Market Insights has announced the addition of the 3D Surgical Microscope Systems Market : Global Industry Analysis 2012 - 2016 and Opportunity
Valley Cottage, NY 10/19/2018 3 D surgical microscope system is an electrically or mechanically worked optical magnifying instrument intended for use in surgical settings for performing microsurgeries. The mix of focal points give stereoscopic vision, amplification going from 4 x 40 x, and enlightened picture of the surgical zone. It has r
10/19/18 - Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant
ABBOTT PARK, Ill., Oct. 19, 2018/ PRNewswire/ Abbott announced today that the HeartMate 3? Left Ventricular Assist Device has received U.S. Food and Drug Administration approval as a destination therapy for people living with advanced heart failure. "Approximately a quarter of a million people are living with advanced heart failure, and many o
10/19/18 - AbbVie and Morphic Therapeutic Announce Collaboration Targeting Fibrotic Diseases
NORTH CHICAGO- AbbVie, a research-based global biopharmaceutical company, and Morphic Therapeutic, a biotechnology company developing oral integrin therapies, announced today that the companies have entered into a research and development collaboration designed to advance a number of Morphic's oral integrin therapeutics for fibrosis-related...
10/19/18 - AcelRx Provides Updated Comments Following Positive FDA Advisory Committee Meeting
In response to opinions expressed following the U.S. Food and Drug Administration Anesthetic and Analgesic Drug Products Advisory Committee meeting on October 12, AcelRx Pharmaceuticals, Inc. stands by the safety, efficacy and medical need for its investigational therapy, DSUVIA?. Developed in collaboration with the Department of Defense, DSUVI
10/19/18 - ADMTs manufacturing, design milestone [Sun, The (Nigeria)]
ADM Tronics Unlimited Inc. officials announced in a recent press release that the company has completed development and engineering to bring the Alvio Respiratory Therapy platform to production-ready status. Announced nearly a year ago, ADMT entered into an agreement with QoL Devices Inc., for development, regulatory activities, and manufacturing o
10/19/18 - AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure [Tehran Times (Iran)]
AELIX Therapeutics S.L., a clinical-stage biotechnology company specialized in the discovery and development of immunotherapies for HIV infection, today announces that it has entered into a clinical research collaboration with Gilead Sciences, Inc., a research-based biopharmaceutical company that discovers, develops and commercializes innovative...
10/19/18 - Amneal Announces Approval of Carmustine for Injection USP, 100 mg/vial - Preparing for Launch
Amneal Pharmaceuticals, Inc., today announced that it has received FDA approval for a generic version of BiCNU for injection, 100 mg. About Amneal Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar
10/19/18 - Amneal Announces the Approval and Launch of Generic Isoproterenol Hydrochloride Injection USP
Amneal Pharmaceuticals, Inc., today announced that it has received FDA approval for a generic version of Isuprel TM Injection USP, 0.2 mg/mL and 1 mg/5 mL Single-Dose Vials. About Amneal Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distri
10/19/18 - Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX2-73
Anavex Life Sciences, a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer s disease, Rett syndrome and other central nervous system diseases, today announced that the Company has received confirmation from the U.S. Food and...
10/19/18 - Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX2-73 in Patients with Rett Syndrome
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer s disease, Rett syndrome and other central nervous system diseases, today announced that the Company has received confirmation from the U.S. Foo
10/19/18 - Antisense Oligonucleotides Market Global Industry Size, Growth, Trends and Forecast 20172027: Future Market Insights has announced the addition of the Antisense Oligonucleotides Market : Global Industry Analysis 2012 - 2016 and Opportunity Ass
Valley Cottage, NY 10/19/2018 Antisense oligonucleotides are 15 25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein. ASOs offers promising treatment options for a range of medical disord
10/19/18 - Apocarotenal Market: Rising Demand for Nature-Identical Colors in the Food and Beverages Industry to Bolster Industry Growth-TMR: Apocarotenal Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026
Albany, NY 10/19/2018 Apocarotenal belongs to the group of plant substances called the carotenoid. The presence of Apocarotenal is usually seen in the citrus fruits and spinach. The main usage of Apocarotenal is in the coloring of food, beverages, cosmetics, and pharmaceutical industry.
10/19/18 - Auto-Injectors Market Expected to Experience Immense Growth to Reach USD 2.4 Billion at 17.2% of CAGR During 20182022: The Medical Devices Market report titled Auto-Injectors Market Research Report- Global Forecast to 2022 is an expert analy
Pune, India 10/19/2018 Auto-Injectors is defined as a medical device which is designed to deliver a single dose of a life-saving drug. Auto injectors are easy to use and are intended for self administration by patients or can be administered by untrained personnel. The Global Auto-Injectors Market is expected to reach USD 2.4 billion by th
10/19/18 - AVITA Medical Announces First U.S. Sales of RECELL System and Commencement of Commercial Shipping [Sport360]
AVITA Medical, a global regenerative medicine company, today announced that it has received the first commercial sales orders from U.S. burn centers for the RECELL Autologous Cell Harvesting Device and has commenced commercial shipment of the product. Our immediate commercial focus is completing the recruitment and training of our U.S. field force.
10/19/18 - Bevacizumab Biosimilar Market Clinical Area Growth Segmentation 2018 to 2025
Harrisburg, NC 10/19/2018 Marketinsightsreports provides "Global Bevacizumab Biosimilar Market Insights, Forecast To 2025" which includes the estimation of market size for value and volume. Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bevacizumab Biosimilar Market, to estimate the size of v
10/19/18 - BioCorRx Strengthens Intellectual Property Portfolio with Acquisition of Several Patent/Patent Pending Families
via NEWMEDIAWIRE BioCorRx Inc., a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that the Company s R&D subsidiary, BioCorRx Pharmaceuticals, has acquired a portfolio of six Therakine Biodelivery GmbH patent families that broadly cover sustained release delivery platforms for t
10/19/18 - Biogen to Present Data from Alzheimer's Disease Portfolio at the 2018 Clinical Trials on Alzheimer's Disease Meeting
CAMBRIDGE- Biogen announced it will present data from its Alzheimer's disease clinical development portfolio at the upcoming Clinical Trials on Alzheimer's Disease annual meeting in Barcelona, Spain. Aducanumab is Biogen's late-stage Alzheimer's disease investigational treatment, and is being co-developed with Eisai. Keynote: What Have We Learned..
10/19/18 - BioLineRx Presents Top-Line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
BL-8040 in combination with KEYTRUDA demonstrated encouraging disease control and overall survival in patients with metastatic pancreatic cancer. Tel Aviv, Israel- BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced top-line results from the dual combination arm of the Phase 2 a...
10/19/18 - BSA Harrington Cancer Center participates in clinical trial focusing on breast cancer [Sport360]
The BSA Harrington Cancer Center has patients enrolled in a new study, aiming to prevent the reoccurrence of breast cancer. The BSA Harrington Cancer Center currently has seven different clinical trials focusing on breast cancer. Some patients at BSA Harrington Cancer Center have the option to join the Breast Cancer Weight Loss trial.
10/19/18 - Calamus Root Market: Emerging Demand Among the Consumers and Product Developers to Benifits the Industry Growth -TMR: Calamus Root Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026
Albany, NY 10/19/2018 Calamus root is rich in vitamin C, hence taken as a dietary vitamin supplement on the regular basis to nourish the replicating cells. Since calamus root supplement is obtained from a natural source, consumers show more towards it. Due to the presence of anti-oxidant nutrients, calamus root is highly utilized in nutraceut
10/19/18 - Can-Fite CEO to present as Expert Speaker on Namodenoson at NASH Summit Europe 2018
PETACH TIKVA- Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver and inflammatory diseases, today announced that its CEO, Dr. Can-Fite's is currently enrolling patients for a Phase II NAFLD/NASH study in three Israeli sites, including Hadassah Medical Center, Jerusalem, and t
10/19/18 - Cancer Supportive Care Drugs Market Worth $23.5 Billion By 2022: Grand View Research, Inc.
According to report by Grand View Research, Inc. The global cancer supportive care drugs market size is expected to be valued at USD 23.5 billion by 2022. The market to be driven by large number of side-effects associated with cancer treatment, increasing uptake of biosimilars, and availability of effective treatment methods, including target speci
10/19/18 - Canon Medical Showcases FDA-Cleared Aquilion Precision at ASTRO 2018
At this year s American Society of Radiation Oncology annual meeting in San Antonio, Texas, October 21-24, 2018, Canon Medical Systems USA, Inc. will showcase its recently FDA- cleared Aquilion Precision TM, the world s first Ultra-High Resolution CT system. The Aquilion Precision sets a new bar for CT imaging, said Dominic Smith, senio
10/19/18 - Cardiac Monitoring Products Market Size, Growth Opportunities and Forecast to 2025
Los Angeles, CA 10/19/2018 This report studies the global market size of Cardiac Monitoring Products in key regions like North America, Europe, Asia Pacific, Central& South America and Middle East& Africa, focuses on the consumption of Cardiac Monitoring Products in these regions. This research report categorizes the global Cardiac Monitoring
10/19/18 - ChemioCare Expands Proprietary Transdermal Platform
ChemioCare USA Inc., a biotech company focused on transforming patient outcomes in cancer supportive care, today announces a successful Drug Enforcement Administration registration: ChemioCare s exclusive formulation development partner, Transdermal Research Pharm Laboratories LLC, has obtained a new registration with the DEA as a Manufacturer
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415